Search results
Showing 1276 to 1290 of 2188 results for guidelines
Discontinued Reference number: GID-NG10287
the UK and were not aimed at all adults living with multimorbidity. The guideline committee believed that there was some evidence that...
Discontinued Reference number: GID-NG10375
Discontinued Reference number: GID-NG10374
NICE has developed a medtech innovation briefing (MIB) on Biopatch for venous or arterial catheter sites .
NICE has developed a medtech innovation briefing (MIB) on Paige Prostate for prostate cancer .
Violence and aggression: short-term management in mental health, health and community settings
Discontinued Reference number: GID-NG10397
Healthy start vitamins: special report on cost effectiveness (ECD5)
This document describes a special report on the cost effectiveness of moving the Healthy Start vitamin programme from the current targeted offering to a universal offering
for decision aids (see www.nice.org.uk/sdm) and are based on the NICE guideline on urinary incontinence and pelvic organ prolapse in...
for decision aids (see www.nice.org.uk/sdm) and are based on the NICE guideline on urinary incontinence and pelvic organ prolapse in...
Discontinued Reference number: GID-NG10384
Discontinued Reference number: GID-NG10396
PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis (MIB313)
NICE has developed a medtech innovation briefing (MIB) on PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis .
NICE has developed a medtech innovation briefing (MIB) on Accuro for guiding epidural or spinal anaesthesia .
Evidence-based recommendations on galcanezumab (Emgality) for preventing migraine in adults.